Stock Events

Stock Events

Amylyx Pharmaceuticals (AMLX) Q4 2025 Earnings

6NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.55

-0.49

-0.43

-0.37

Details

Expected EPS

-0.435825

Actual EPS

-0.37

Surprise EPS

0.07

Surprise Percent

+15.1%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -0.37 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.